©2024 Stanford Medicine
Preimplantation Genetic Testing in Women of Advanced Maternal Age
Not Recruiting
Trial ID: NCT04167748
Purpose
The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes
of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single
embryo transfer in women between 35 and 40 years of age.
Official Title
GEnetic Testing in Elective Single Embryo Transfer in Women of Advanced Maternal Age
Stanford Investigator(s)
Ruth Lathi, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Eligibility
Inclusion Criteria:
- Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
- Utilization of Intracytoplasmic Sperm Injection ICSI
- Utilization of ejaculated or testicular sperm
- Utilization of autologous or donor sperm
- All Controlled Ovarian Hyperstimulation (COH) protocols
Exclusion criteria:
- Patients with anovulatory Polycystic ovarian syndrome (PCOS)
- Utilization of donor oocytes
- Utilization of gestational carrier
- Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
- Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers
Intervention(s):
procedure: Preimplantation genetic testing for aneuploidy (PGT-A)
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Ruth B Lathi, MD
6504987911